Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$0.27 - $0.5 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022

BUY
$0.37 - $0.54 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
$0.34 - $0.86 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
$0.44 - $0.63 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021

BUY
$0.48 - $0.72 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$0.68 - $1.25 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$0.38 - $0.78 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020

BUY
$0.47 - $0.64 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$0.41 - $0.73 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020

BUY
$0.36 - $0.79 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.75 - $0.89 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$0.78 - $1.09 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

BUY
$0.98 - $1.64 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

BUY
$0.67 - $1.01 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019

BUY
$0.63 - $1.0 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018

BUY
$0.88 - $1.1 $0 - $0
0 New
0 $0

Others Institutions Holding PTN

About PALATIN TECHNOLOGIES INC


  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $17.5M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.